Home › Interstitial Lung Diseases › South Carolina › Charleston
Interstitial Lung Diseases clinical trials in Charleston, SC
13 studies for Interstitial Lung Diseases are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RecruitingPhase 3
- Lowcountry Lung and Critical Care, Charleston
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RecruitingPhase 3
- Medical University of South Carolina, Charleston
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 2
- MUSC, Charleston
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Recruiting
- Medical University of South Carolina, Charleston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Medical University of South Carolina, Charleston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Charleston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- Medical University of South Carolina, Charleston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Medical University of South Carolina (MUSC), Charleston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Medical University of South Carolina, Charleston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Medical University of South Carolina-Nexus, Charleston
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
RecruitingObservational study
- Medical University of South Carolina, Charleston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, Charleston
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Kansas City, KS13 studies
- Durham, NC13 studies
- Chicago, IL12 studies
- Houston, TX12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Salt Lake City, UT9 studies
- Dallas, TX9 studies
- Boston, MA9 studies
Other studies in Charleston
- Depression19 studies
- Stroke18 studies
- Heart Failure18 studies
- Non-Small Cell Lung Cancer16 studies
- Post-Traumatic Stress Disorder16 studies
- Cardiovascular Disease15 studies
- Prostate Cancer15 studies
- Cancer (all types)14 studies
- Head and Neck Squamous Cell Carcinoma14 studies
- Parkinson's Disease13 studies
- Breast Cancer12 studies
- Lung Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.